Literature DB >> 11819441

The mechanism of actions of Octreotide, Bupleurum-Peony Cheng Qi decoction and Dan Shan in severe acute pancretitis.

Xie-Ning Wu.   

Abstract

Entities:  

Year:  1999        PMID： 11819441      PMCID： PMC4688480          DOI： 10.3748/wjg.v5.i3.249

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  10 in total

1.  Management of severe acute pancreatitis.

Authors:  Xie-Ning Xu
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

2.  [Clinical and experimental study of effect on acute phase protein level of multiple organ dysfunction syndrome treated with dachengqi decoction].

Authors:  Q Zhao; N Cui; J Li
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  1998-08

3.  Calcium channel blockade inhibits release of TNF alpha and improves survival in a rat model of acute pancreatitis.

Authors:  C B Hughes; A B el-Din; M Kotb; L W Gaber; A O Gaber
Journal:  Pancreas       Date:  1996-07       Impact factor: 3.327

4.  Endogenous glucocorticoids decrease the acinar cell sensitivity to apoptosis during cerulein pancreatitis in rats.

Authors:  K Kimura; T Shimosegawa; H Sasano; R Abe; A Satoh; A Masamune; M Koizumi; H Nagura; T Toyota
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

5.  Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.

Authors:  K Shiratori; S Watanabe; T Takeuchi
Journal:  Pancreas       Date:  1991-01       Impact factor: 3.327

6.  Effects of long-acting somatostatin analog (SMS 201-995) on eicosanoid synthesis and survival in rats with acute necrotizing pancreatitis.

Authors:  B van Ooijen; C J Tinga; W J Kort; F J Zijlstra; S W Lamberts; J H Wilson
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

7.  Protective effect of the somatostatin analogue octreotide in ischemia/reperfusion-induced acute pancreatitis in rats.

Authors:  T F Hoffmann; E Uhl; K Messmer
Journal:  Pancreas       Date:  1996-04       Impact factor: 3.327

8.  [Changes of inflammatory mediator in aucte necrotizing pancreatitis and effect of somatostatin analogne stilamin in rats].

Authors:  Q Zhang; D Cai; S Wu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  1997-05

9.  The long-acting somatostatin analogue octreotide decreases pancreatic islet blood flow in rats.

Authors:  P O Carlsson; L Jansson
Journal:  Pancreas       Date:  1994-05       Impact factor: 3.327

Review 10.  Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis.

Authors:  M W Büchler; M Binder; H Friess
Journal:  Gut       Date:  1994       Impact factor: 23.059
  10 in total
  6 in total

1.  Treatment revisited and factors affecting prognosis of severe acute pancreatitis.

Authors:  Xie-Ning Wu
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Current concept of pathogenesis of severe acute pancreatitis.

Authors:  Xie-Ning Wu
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

Review 3.  Enteral nutrition and acute pancreatitis.

Authors:  Q P Chen
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

4.  Pancreatic microcirculatory impairment in experimental acute pancreatitis in rats.

Authors:  Zong-Guang Zhou; You-Dai Chen; Wei Sun; Zhong Chen
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

5.  Severe acute pancreatitis in the elderly: etiology and clinical characteristics.

Authors:  Ming-Jun Xin; Hong Chen; Bin Luo; Jia-Bang Sun
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

6.  Comparative effectiveness of elemental formula in the early enteral nutrition management of acute pancreatitis: a retrospective cohort study.

Authors:  Akira Endo; Atsushi Shiraishi; Kiyohide Fushimi; Kiyoshi Murata; Yasuhiro Otomo
Journal:  Ann Intensive Care       Date:  2018-06-05       Impact factor: 6.925
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.